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Abstract
Introduction: We explored the diagnostic value of a urine soluble triggering receptor expressed on myeloid cells-1
(sTREM-1) for early sepsis identification, severity and prognosis assessment, and for secondary acute kidney injury
(AKI). We compared this with white blood cell (WBC) counts, serum C-reactive protein (CRP), serum procalcitonin
(PCT), urine output, creatinine clearance (CCr), serum creatinine (SCr), and blood urea nitrogen (BUN).
Methods: We enrolled 104 subjects admitted to the ICU: 16 cases with systemic inflammatory response syndrome
(SIRS); 35 with sepsis and 53 with severe sepsis. Results for urine sTREM-1, WBC, serum CRP and serum PCT were
recorded on days 1, 3, 5, 7, 10, and 14. For 17 sepsis cases diagnosed with secondary AKI, comparisons between
their urine sTREM-1, urine output, CCr, SCr and BUN at diagnosis and 48 h before diagnosis were made.
Results: On the day of admission to the ICU, and compared with the SIRS group, the sepsis group exhibited
higher levels of urine sTREM-1 and Acute Physiologic Assessment and Chronic Health Evaluation II (APACHE II)
scores (P < 0.05). Areas under the curve (AUC) shaped by the scores were 0.797 (95% CI 0.711 to 0.884) and 0.722
(95% CI 0.586 to 0.858), respectively. On days 1, 3, 5, 7, 10, and 14, urine sTREM-1, serum PCT and WBC levels
registered higher in the severe sepsis group in contrast to the sepsis group (P < 0.05). Urine sTREM-1 and serum
PCT levels continuously increased among non-survivors, while WBC and serum CRP levels in both groups declined.
For 17 patients with AKI, urine sTREM-1, SCr and BUN levels at 48 h before AKI diagnosis were higher, and CCr
level was lower than those for non-AKI subjects (P < 0.05). AUC for urine sTREM-1 was 0.922 (95% CI 0.850 to
0.995), the sensitivity was 0.941, and the specificity was 0.76 (based on a cut-off point of 69.04 pg/ml). Logistic
regression analysis showed that urine sTREM-1 and severity were risk factors related to AKI occurrence.
Conclusions: Besides being non-invasive, urine sTREM-1 testing is more sensitive than testing WBC, serum CRP,
and serum PCT for the early diagnosis of sepsis, as well as for dynamic assessments of severity and prognosis. It
can also provide an early warning of possible secondary AKI in sepsis patients.
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Sepsis is a major factor contributing to ICU admissions
and patient deaths. A recent epidemiologic study in North
America found that the incidence of sepsis was 3% in the
total population and that the mortality rate for septic
shock patients was as high as 50% [1]. Because of its rapid
progression, the disease might, within a relatively short
period of time, lead to secondary multiple organ dysfunc-
tion syndrome (MODS) and endanger a patient’s life [2].
Acute kidney injury (AKI) is well known to be associated
with longer length of stay, morbidity and mortality in
adults [3,4]. Sepsis-related kidney failure occurs in about
19% of sepsis patients. This incidence may reach 23%
among severe sepsis patients and is 51% among those with
positive blood cultures, with a mortality rate of 70%, much
higher than among patients who are free from these com-
plications [5]. Clinical practice has shown that for patients
with severe sepsis and septic shock, an early, effective
intervention can clearly improve prognosis and reduce
mortality [6]. For this reason, it is clinically important to
identify indicators that can be used for the early diagnosis
and prognosis of sepsis and its related AKI.
The triggering receptor expressed on myeloid cells-1
(TREM-1) is a recently discovered member of the immu-
noglobulin superfamily of receptors that is expressed on
polymorphonuclear granulocytes and mature monocytes.
Bacterial or fungal infections may induce its expression.
sTREM-1 is a soluble form of TREM-1 that may be
released into body fluids upon the up-regulated expres-
sion of TREM-1 [7]. An increasing number of studies
indicate that there are increased levels of sTREM-1 in
body fluid samples for the following diseases and condi-
tions: sepsis, pneumonia, pleural effusion, septic arthritis,
meningitis, peritonitis and uterine cavity infection [8-14].
This suggests that sTREM-1 may be a valuable diagnostic
indicator for making distinctions between infectious and
non-infectious diseases. It has also been found that infec-
tious shock patients have high levels of serum sTREM-1
that are closely related to the severity of infection [15,16].
With regard to sepsis prognosis, dynamic changes in
serum sTREM-1 may provide warnings concerning survi-
val or fatality [17,18].
Inflammation is now believed to play a major role in the
pathophysiology of AKI [19,20]. It is hypothesized that the
initial insult results in morphological and/or functional
changes in vascular endothelial cells and/or in tubular
epithelium in sepsis models [21,22]. Then, leukocytes
including neutrophils, macrophages, natural killer cells,
and lymphocytes infiltrate into the injured kidneys and
induce the generation of inflammatory mediators [23,24].
Whether urine sTREM-1 could be detected and its signifi-
cance in sepsis and AKI have not been reported yet.
T h ep r e s e n ts t u d yf o c u s e do nt h ev a l u eo fu r i n e
sTREM-1 for sepsis identification, severity and prognosis
assessments, and potential sepsis-related AKI. Compari-
s o n sa r ea l s om a d ea m o n gs T R E M - 1 ,W B Cc o u n t s ,
serum CRP, serum procalcitonin (PCT), urine output,
creatinine clearance (CCr), SCr, and blood urea nitrogen
(BUN) among sepsis patients, in an effort to define rele-
vant diagnostic values.
Materials and methods
Study subjects
All subjects were selected from among inpatients who
were hospitalized between March 2010 and March 2011
in the Respiratory ICU, Surgical ICU and Emergency
ICU of Chinese People’s Liberation Army (CPLA) Gen-
eral Hospital. Based on the 1991 ACCP/SCCM Sepsis
Directory [25] and the diagnosis criteria advanced by
the 2001 International Sepsis Definition Conference
[26], the subjects were divided into a systemic inflam-
matory response syndrome (SIRS) group and a sepsis
group, with the occurrence of infection as the norm for
division. Based on the severity of their conditions, the
latter was sub-divided into a sepsis group and a severe
sepsis group (severe sepsis and septic shock). Sepsis
patients were also divided into a survivor group and a
non-survivor group, with a 28-day survival as the divid-
ing line. This study focuses on dynamic changes of dif-
ferent indicators. For this, all the patients involved
stayed in ICUs ≥ 14 days or died within 14 days.
T h e2 0 0 6A c u t eK i d n e yI n j u r yN e t w o r k( A K I N )
defines AKI as different degrees of abnormal kidney
structure and function as well as abnormal kidney
damage signs lasting not more than three months, and
manifested clinically by blood, urine and tissue tests and
imaging studies [27], characterized by a 48 h absolute
increase in serum creatinine (SCr) ≥ 26.4 μmol/L (0.3
mg/dL) or a percentage increase ≥ 50%, or a ≥ 6h
decline in urine output to ≤ 0.5 ml/kg·h.
Patients excluded: (1) were younger than 18 years of
age; (2) suffered from anuria; (3) contracted acquired
immunodeficiency syndrome; (4) had reduced polymor-
phonuclear granulocyte counts (< 500 μL
-1); (5) were
receiving dialysis treatment for chronic kidney disease;
(6) died within 24 h after admission into the ICU, or
refused to participate in the study, or declined treatment
during the period of observation. Patients or their family
members were fully informed of the study details and
signed informed consent forms of their own accord.
This study was approved by the Ethics Committee of
the CPLA General Hospital (project No.20090923-001)
and was registered with the U.S. National Institutes of
Health Clinical Trials Register (NCT 01333657).
Data collection
Upon admission into the ICU, the following items were
recorded for each patient: age, gender, chief complaints
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Page 2 of 10for admission, symptoms, APACHE II scores, Sequential
Organ Failure Assessment (SOFA) scores, white blood
cell (WBC) counts, serum c-reactive protein (CRP),
P C T ,u r i n es T R E M - 1 ,C C r ,S C r ,B U N ,u r i n eo u t p u t ,
mechanical ventilation, continuous renal replacement
treatment (CRRT), AKI, etiological factors and underly-
ing diseases. A record was also kept of 28-day survivals.
Assays
Within 24 h (the first day of study) after ICU admission,
blood and urine samples were collected. Tests on intra-
venous blood and urine samples were repeated on the
mornings of days 3, 5, 7, 10, and 14. Blood was centri-
fuged at 3,000 rpm for 15 minutes, and urine at 2,000
rpm for 5 minutes. The supernatants were transferred
to Eppendorf tubes and stored at -80°C. All the speci-
mens were re-numbered before the experiment. We saw
to it that each step was blind to the staffers involved.
sTREM-1 was examined by a double antibody sandwich
ELISA (Quantikine Human TREM-1 Immunoassay
ELISA Kit, R & D Systems, Minneapolis, MN, USA, pro-
duct number DTRM10B); CRP, by scattering turbidime-
try (Cardio Phase hsCRP, Siemens, Munich, Germany);
PCT, by enzyme-linked fluorescence analysis (ELFA,
V I D A SB R A H M SP C Tk i t ,BioMérieux, Marcy-l’Étoile,
France) and SCR and BUN, by an enzymatic method
(CREA plus & UREA/BUN reagent, Roche Modular,
Mannheim, Germany). ELISA was performed in dupli-
cate and other assays were done in strict accordance
with the manufacturers’ instructions.
Statistical analysis
Results for continuous variables with normal distribu-
tions, including age, WBC counts, urine output, CCr,
APACHE II scores and SOFA scores are given as means
± standard deviations (SD). Student’s t-test was used to
compare means between two groups. Analysis of var-
iance (ANOVA) was used to compare means among
multiple groups. Results for continuous variables that
were not normally distributed, including sTREM-1,
CRP, PCT, SCr and BUN, are given as medians (25
th
and 75
th percentiles) and were compared using non-
parametric tests. Results for qualitative variables were
expressed as percentages and compared between groups
using a Chi-square test. Areas under receiver operating
characteristic curves were used to evaluate how well the
model distinguished sepsis patients from SIRS patients,
and AKI patients from non-AKI patients. Multivariate
analysis used a logistic regression model to estimate the
odds ratio for AKI and the 95% confidence interval (CI).
Stepwise and forward selection procedures were used to
iteratively select variables possibly related to AKI. To be
entered into this model, a P < 0.05 from univariate ana-
lysis was required. Risk factors related to disease were
explored using multivariate logistic regression. Statistical
analyses were conducted by SPSS 16.0 (SPSS, Chicago,
IL, USA) and a two-tailed P < 0.05 was considered
significant.
Results
Subject characteristics
A total of 205 patients with SIRS were involved in the
study. Of these, 21 patients were later excluded accord-
ing to the exclusion criterion. Of the remaining 184
patients, 56 were barred from analysis for a less-than-
14-day ICU stay (because of later admission or a trans-
fer out of ICUs within 14 days, which fails the require-
ments of continuous observation). Later we sifted out 24
more owing to the limited concentration range of R&D
sTREM-1 assay kit. Finally, this study had 104 subjects
involved, which included 16 cases of SIRS and 88 cases
of sepsis. According to the study guidelines, sepsis
patients were further divided into a sepsis group (35
cases) and a severe sepsis group (25 with severe sepsis
and 28, septic shock). Of the 88 people, 19 developed
AKI upon or 24 h after ICU admission, and 17 devel-
oped it more than 48 h after admission, while the
remaining 52 were safe from AKI during the
observation.
Table 1 provides a general summary of the subjects’
conditions. WBC counts and serum PCT levels in the
severe sepsis group were higher than that of the sepsis
group (P =0 . 0 0 2 ,P < 0.001). There were statistically
significant differences in urine sTREM-1 level and dis-
ease severity scores, including APACHE II and SOFA
scores, among the three groups of patients upon ICU
admission (P < = 0.001). In terms of kidney function,
the SCr and BUN levels for the severe sepsis group
tended to be higher than sepsis group (P <0 . 0 1 ) .T h e
number of severe sepsis patients that required CRRT
was greater than for the sepsis group (P =0 . 0 1 7 ) .M o r e
patients developed AKI in the severe sepsis group (P <
0.001). Regarding the 28-day survivals, mortality rates
for the severe sepsis group were the highest, followed by
the sepsis group, and the SIRS group had the lowest
rate (P < 0.001). Statistically, no significant cross-group
difference exists in terms of age, gender, serum CRP,
urine output, mechanical ventilation, etiological factors,
or accompanying underlying diseases.
Comparisons of urine sTREM-1, WBC counts, serum CRP,
and serum PCT levels, and APACHEII scores: for the
purpose of early sepsis diagnosis
On the first day of enrollment, urine sTREM-1, WBC
counts, serum PCT and APACHE II scores of the sepsis
group had higher values than the SIRS group (Table 1).
However, only differences in urine sTREM-1 level and
APACHE II score between the groups proved
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Operating Characteristicc u r v e s( R O C s )o fu r i n e
sTREM-1 and APACHE II for sepsis diagnosis.
Dynamic changes in urine sTREM-1, WBC counts, serum
CRP and serum PCT levels: for the assessments of the
severity and prognosis of sepsis
Figure 2 shows comparisons between the sepsis and
severe sepsis groups for urine sTREM-1, WBC counts,
s e r u mC R Pa n ds e r u mP C To nd a y s1 ,3 ,5 ,7 ,1 0 ,a n d
14. The differences in urine sTREM-1, WBC counts and
serum PCT levels at these six different time points were
statistically significant, with the severe sepsis group hav-
ing all-time higher values, and also showing a higher
CRP level on days 5, 7, and 10, which were also statisti-
cally significant.
Based on 28-day survivals, the 88 sepsis patients were
divided into a survivor group (n = 47) and a non-survi-
vor group (n = 41). Figure 3 compares these two groups
for their dynamic changes in urine sTREM-1, WBC
Table 1 Clinical and biological data at admission according to the guideline for diagnosis of sepsis
Characteristics SIRS Sepsis
N = 16 total n = 88 sepsis n = 35 severe sepsis n = 53
Age (years) 51 ± 18 60 ± 19 58 ± 21 62 ± 17
Gender (n, %)
Male 3 (19) 23 (26) 24 (69) 41 (77)
Female 13 (81) 65 (74) 11 (31) 12 (24)
WBC counts (×10
∧9/L) 11.3 ± 2.8 12.9 ± 6.7 10.5 ± 3.9 14.4 ± 7.7
#
Serum CRP (mg/dl) 11.4 (5.9, 15.2) 9.5 (4.1, 17.2) 8.1 (2.5, 14.7) 11.8 (6.1, 18.6)
Serum PCT (ng/ml) 1.2 (0.3, 9.5) 2.7 (0.4, 11.1) 0.4 (0.1 to 2.1) 4.5 (1.2 to 19.4)
#
Urine sTREM-1 (pg/ml) 11.8 (3.6, 24.1) 61.5 (21.3, 173.7)* 28.0 (10.5, 78.8) 83.3 (39.6, 259.7)
#
Renal characteristics
Urinary output (ml/Kg/hr) - 1.2 ± 0.6 1.3 ± 0.5 1.1 ± 0.7
SCr (μmmol/L) 83.2 (69.25, 104.75) 85 (60.5, 134.4) 65.9 (48.0, 99.9) 90.8 (64.4, 167.7)
#
BUN (mmol/L) 7.9 (4.9, 13.2) 10.4 (7.5, 16.9) 8.0 (6.5, 10.6) 12.7 (8.8 (28.9))
#
APACHE II score 11.5 ± 7.6 17.5 ± 7.5* 13.4 ± 6.1 20.2 ± 7.1
#
SOFA score - 8.6 ± 3.7 5.8 ± 2.9 10.0 ± 3.5
#
MV (n, %) 12 (75.0) 74 (86.0) 29 (82.9) 45 (84.9)
CRRT (n, %) 2 (12.5) 25 (28.4) 5 (14.3) 20 (37.7)
#
AKI (n, %) 2 (12.5) 36 (39.8)* 4 (11.4) 31 (58.5)
#
Etiological factors (n, %)
Pulmonary infection - 75 (85.2) 31 (88.6) 44 (83.0)
Abdominal infection - 22 (25.0) 7 (20.0) 15 (28.3)
Urinary tract infection - 25 (28.4) 13 (37.1) 12 (22.6)
Trauma/postoperative infection - 33 (37.5) 10 (28.6) 23 (43.4)
Bacteremia - 19 (21.6) 9 (25.7) 10 (18.9)
Catheter-related infections - 13 (14.8) 8 (22.9) 5 (9.4)
Others - 4 (4.5) 0 (0.0) 4 (7.5)
Underlying diseases (n, %)
Hypertension 5 (31.2) 32(332 (36.4) 12 (34.3) 20 (37.7)
Diabetes 1 (6.2) 14 (15.9) 5 (14.3) 5 (9.4)
COPD 1 (6.2) 9 (10.2) 5 (14.3) 4 (7.5)
Coronary heart disease 4 (25.0) 17 (19.3) 5 (14.3) 12 (22.6)
Immunosuppressed 0 (0.0) 9(10.2) 2 (5.7) 7 (13.2)
Nervous system disease 2 (12.5) 12(13.6) 5 (14.3) 7 (13.2)
CKD 1 (6.2) 5(5.7) 1 (2.9) 4 (7.5)
Mortality rate (n, %) 1 (6.2) 41(46.6)* 7 (20.0) 34 (64.2)
#
Quantitative data of normal distribution are presented as mean ± SD. Quantitative data of non-normal distribution are presented as median (25th and 75th
percentiles). Qualitative data are presented as n (%). * represents the comparison between SIRS and sepsis, P < 0.05; # represents the comparison between sepsis
and severe sepsis, P < 0.05.
AKI, acute kidney injury; APACHE II score, acute physiologic assessment and chronic health evaluation II scores; BUN, blood urea nitrogen; CKD, chronic kidney
disease; CRP, C-reactive protein; CRRT, continuous renal replacement treatment; MV, mechanical ventilation; NS, not significant; PCT, procalcitonin; SCr, serum
creatinine; SOFA score, sequential organ failure assessment scores; sTREM-1, soluble triggering receptor expressed on myeloid cells-1; WBC, white blood cells.
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of survivors decreased with time (41, 41, 32, 25, 13 and
7 people on days 1, 3, 5, 7, 10, and 14 respectively).
Therefore, for those who died within 14 days, indicator
values obtained at the last test before death were substi-
tuted for indicator values at later times after death. The
curves in Figure 3 show that the non-survivor group
had higher urine sTREM-1, WBC counts, serum CRP
and serum PCT levels than the survivor group over this
period of time. As for non-survivors, their urine
sTREM-1 and serum PCT levels increased with the pas-
sage of time, while their WBC counts and serum CRP
levels tended to decline. The survivor group exhibited
no obvious changes in urine sTREM-1 levels, while their
WBC counts, serum CRP, and serum PCT levels were
obviously on the decline.
Urine sTREM-1: diagnostic value for AKI
Of the 88 severe sepsis cases, 19 developed AKI upon or
within 24 h of their ICU admission, and 17 developed
AKI 48 h later. The other 52 did not develop AKI com-
plications during the time of observation. Table 2 shows
the results for the 17 AKI patients who developed AKI
before 48 h diagnosis of AKI, such as urine sTREM-1,
urine output, CCr, SCr and BUN. Table 2 also shows
these indicators’ levels upon ICU admission for the 52
patients that did not develop complications. Compari-
sons were made between these two groups of patients.
The AKI patients’ urine sTREM-1 levels at 48 h before
diagnosis were significantly higher than those for the
non- AKI patients (P < 0.001). The AKI patients’ CCr,
SCr and BUN levels at 48 h before diagnosis were also
higher than for the non-AKI patients (P < 0.05).
Multivariate logistic regression was used to assess possi-
ble risk factors for AKI occurrence. The variables taken
into consideration here include severity of sepsis, urine
output, CCr, SCR, BUN, urine sTREM-1 and a history of
chronic kidney disease. First, from univariate analyses,
four variables were selected for multivariate regression:
severity, CCr, SCR and urine sTREM-1. Finally, only urine
sTREM-1 and severity were entered into the regression
equation. Urine sTREM-1 with a regression coefficient =
0.02, OR = 1.02 and Wald coefficient = 5.246 (P = 0.022).
Severity with a regression coefficient = 2.074, OR = 7.956
and Wald coefficient = 5.204 (P = 0.023).
Figure 4 shows ROC curves for AKI diagnosis for
urine sTREM-1, SCR, and BUN levels. The correspond-
ing AUCs were as Table 3. Using a cut-off point of
69.04 pg/ml for sTREM-1, the sensitivity turns out
0.941 and the specificity, 0.760.
Discussion
Sepsis is a quite common cause of critical diseases and
complications, and one of the risk factors for AKI and
MODS [28]. When an infection occurs, lipopolysacchar-
ides, lipopeptides, microbial DNA, peptide polysacchar-
ides, lipoteichoic acid and other substances can trigger
innate immune reactions mediated by Toll-like receptors
(TLRs), NOD-like receptors (NLRs), and other relevant
molecules, such as MyD88, and so on. These can subse-
quently engender both humoral and cellular immune
responses. Through the actions of various signals,
numerous cytokines, metabolic products of arachidonic
acid, leukotrienes, thrombosis-forming substances and
inflammatory mediators are produced. In addition, com-
plement and coagulation pathways are activated [29,30].
In case of sepsis, systemic inflammatory factor-induced
immune reactions, such as innate and adaptive immune
responses, play a critical role in the induction and devel-
opment of organ dysfunctions, such as AKI [23,31]. This
may result from increased expressions of TLRs and
NLRs on renal tubule epithelia as well as local endothe-
lial cells inside the kidney. This can cause localized
inflammatory reactions in the kidney and oxidative
stress, as well as inducing epithelial and endothelial cell
injury, and induce changes in the glomerular pore dia-
meter and charge barrier [24,32]
Our study shows that urine sTREM-1 has a positive
predictive value for the early diagnosis of sepsis. We do
Figure 1 ROC curves for urine sTREM-1 and APACHEII for
distinguishing sepsis from SIRS. Area under the curve (AUC)
turned out respectively as urine sTREM-1 0.797 (95% CI 0.711 to
0.884) and APACHE II score 0.722 (95% CI 0.586 to 0.858). Using a
cut-off point for urine sTREM-1 of 34.2 pg/ml, the sensitivity was
0.643, the specificity was 0.938, Positive Predictive Value (PPV) was
0.983, Negative Predictive Value (NPV) was 0.198 and Youden index
(YI) was 0.581. Using a cut-off point for APACHE II score of 13.5, the
sensitivity was 0.714, the specificity was 0.625, PPV was 0.913, NPV
was 0.197 and YI was 0.339. ROC curves, Receiver Operating
Characteristic curves;sTREM-1, soluble triggering receptor expressed
on myeloid cells-1; APACHEII, acute physiologic assessment and
chronic health evaluationII;SIRS, systemic inflammatory response
syndrome.
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between SIRS and sepsis patients upon their ICU admis-
sion in urine sTREM-1 level and APACHE II score.
R O Cc u r v e sa n a l y s i sd i s p l a y st h a tt h eu r i n es T R E M - 1
AUC is conspicuously higher than any other indicator
and its sensitivity reaches 0.643.
While conducting dynamic assessments of the severity
and prognosis of sepsis, we found that a severe sepsis
group exhibited higher urine sTREM-1, WBC, and
serum PCT level than a sepsis group on days 1, 3, 5, 7,
10, and 14, reckoned from ICU admission (P < 0.05).
A l lt h i sp o i n t st ot h ev a l u eo fu r i n es T R E M - 1 ,W B C ,
and serum PCT, as biomarkers, in the discrimination of
severe (severe sepsis + septic shock) accompanied by
organ dysfunction. Moreover, the differences in these
indices between the two groups were observed even on
the first day of ICU admission, which is conducive to an
early diagnosis of severe sepsis and a timely
intervention.
During the 14 days of observation, the non-survivors’
urine sTREM-1 levels continued to climb with the pas-
sage of time, while the survivors’ remained relatively
lower. This suggests that urine sTREM-1 may have
connections with the prognosis of the disease, and that
its continuous, relatively lower expression indicates that
the inflammatory response has been brought under con-
trol and prognosis might be better. In contrast, in the
case of non-survivors, the sTREM-1 level, possibly
owing to positive feedback provided by downstream
inflammatory factors, rises continually [33,34]. Because
of extracellular partial exfoliation brought about by
metalloproteinase proteolysis, TREM-1 gives rise to its
27 kDa soluble protein sTREM-1 [15,35], which suggests
the release of additional pro-inflammatory cytokines and
mediators as well as a continuous or progressive overac-
tive inflammatory response and a poor prognosis. The
non-survivors’ WBC counts, serum CRP, and serum
PCT levels measured higher than those of the survivors
during the corresponding period, suggesting a poor
prognosis. However, the non-survivors’ WBC count and
serum CRP level tended to go down towards the end of
the course of the disease. All this suggests that the
dynamic changes in urine sTREM-1 and serum PCT
may well reflect the body’s inflammatory responses and
the prognosis of sepsis. These two indicators provide
more ideal medical tips than WBC counts and serum
Figure 2 sTREM-1 (A), WBC (B), CRP (C), and PCT (D) levels measured over 14 days at different stages of sepsis..*P < 0.05, **P < 0.01, ***P <
0.001. CRP, C-reactive protein; PCT, procalcitonin; sTREM-1, soluble triggering receptor expressed on myeloid cells-1; WBC, White blood cells.
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Page 6 of 10Figure 3 sTREM-1 (A), WBC (B), CRP (C), and PCT (D) levels measured over 14 days based on 28-day survival. The differences of patients
diagnosed with sepsis in urine sTREM-1 and serum PCT levels at these six different time points were statistically significant (P < 0.05), with the
non-survivors group having higher values at all time points, and also showing a higher CRP level on days 7, 10 and 14, which were also
statistically significant (P < 0.05). WBC counts in the non-survivors group were also higher than that of the survivors group, but with no apparent
difference between them at all time points. CRP, C-reactive protein; PCT, procalcitonin; sTREM-1, soluble triggering receptor expressed on
myeloid cells-1; WBC, white blood cells.
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PCT levels may signify a bad prognosis
We discovered that 48 h before AKI occurrence, in
contrast with a non-AKI group, that AKI patients had an
obvious increase in urine sTREM-1 (P < 0.001). The
AUC for an ROC curve was 0.922 (95% CI: 0.850 to
0.995), sensitivity was 0.941% (based on a cut-off point of
69.04 pg/ml), and specificity, 0.76. Although the AKI
group exhibited higher SCr and BUN level than the non-
AKI group before AKI occurrence, a sharp rise was
observed only after AKI occurrence. It, therefore, can be
deduced that urine sTREM-1 has its value for early sepsis
diagnosis, while the indices of SCR and BUN are more
significant for assessing the progress of AKI. For our
multivariate logistic regression, urine sTREM-1 and sep-
sis severity were factors entered into the final regression
equation, which suggests that throughout the study per-
iod, urine sTREM-1 and severity are to be regarded as
possible risk factors and urine sTREM-1 possesses poten-
tial significance for the assessment of kidney function.
The present study also has some limitations. (1) The
sample size was not sufficiently large, including only 17
cases with AKI diagnosed 48 h after ICU admission. For
this reason, no statistical significance was found with
regards to whether urine sTREM-1 has relevance to
AKIN classification (no data reported in this regard) [27].
(2) Blood and urine samples were collected every other
day, and not on a day-to-day basis. Therefore, no assess-
ments could be made of kidney function 24 h before AKI
occurrence. It cannot be ruled out that renal function
decline already existed before AKI diagnosis. (3) There
are reports that there are no obvious changes in urine
sTREM-1 levels with urinary tract infections [36]. It is,
therefore, predicted that a rise in urine sTREM-1 is an
inflammatory factor-induced localized kidney immune
response brought on by sepsis, not solely by localized
inflammatory responses [23,31]. On account of this, the
present study does not involve cases with urinary tract
infection. (4) In our study, the average CRRT duration
for AKI patients measures 11.6 ± 3.8 h per day. In virtue
of not receiving continuously renal replacement therapy,
the AKI patients in our study might still be featured with
a larger quantity of inflammatory factors in their body. In
consideration of the sample size, we did not exclude
those who received CRRT from this study.
Conclusions
Urine sTREM-1 may play a role in the early diagnosis of
sepsis. The dynamic change in urine sTREM-1 may be an
aid to distinguish severity of sepsis, and be more accurate
and sensitive than traditional indicators for the dynamic
assessments of prognosis. We find that urine sTREM-1
has significance in the early diagnosis of sepsis-related
AKI, and could likely become a new marker for such
injuries. Owing to the limitations of our sample size, pro-
spective clinical studies are still wanted to provide further
proof for the clinical diagnostic value of urine sTREM-1.
In addition, further studies are to be expected on the role
and mechanisms of urine sTREM-1 for AKI.
Table 2 Comparison diagnostic value of sTREM-1, urinary output, CCr, SCr, BUN levels for AKI before 48 hours
Parameters AKI Non- AKI P-value
N=1 7 N=5 2
urine sTREM-1 (median-25th and 75th percentiles, pg/ml) 288.74 (108.65, 524.07) 35.66 (7.92, 75.73) < 0.001
urinary output (mean ± SD, ml/Kg/hr) 1.28 ± 0.62 1.62 ± 0.70 0.086
CCr (mean ± SD, ml/minute) 55.59 ± 30.95 104.28 ± 60.94 0.002
Scr (median-25th and 75th percentiles, μmmol/L) 105.0 (71.7, 176.15) 65.0 (52.18, 90.98) 0.001
BUN (median-25th and 75th percentiles, mmol/L) 17.53 (8.02, 29.73) 8.97 (6.66, 12.43) 0.038
sTREM-1, soluble triggering receptor expressed on myeloid cells-1;CCr, creatinine clearance; SCr, serum creatinine; BUN, blood urea nitrogen; AKI, acute kidney
injury.
Figure 4 ROC curves for urine sTREM-1, SCr, BUN level for
diagnosing AKI before 48 hours. ROC curves, Receiver Operating
Characteristic curves;sTREM-1, soluble triggering receptor expressed
on myeloid cells-1; SCR, serum creatinine; BUN, blood urea nitrogen;
AKI, acute kidney injury.
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Page 8 of 10Key messages
￿ Identification of infection on classic biomarkers is
insufficient. But urine sTREM-1 may turn out the
most reliable marker for sepsis and its severity.
￿ Dynamic changes in urine sTREM-1 are more
accurate and sensitive than traditional indicators for
the dynamic assessments of severity and prognosis
of sepsis.
￿ Urine sTREM-1 can also provide an early warning
of possible secondary AKI in sepsis patients. It is
likely to be a risk factor and has potential signifi-
cance for the assessment of kidney function.
￿ Urine sTREM-1 is likely to become a biomarker
with optimistic prospects of clinical application.
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